NeoGenomics Inc (NEO) — Cash Flow Reinvestment Rate
NeoGenomics Inc (NEO) has a Cash Flow Reinvestment Rate of 5.86x as of December 2025, reinvesting $7.87 Million (capex $7.87 Million ) from operating cash flow of $1.34 Million. Check how high is NeoGenomics Inc's earnings quality to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
NeoGenomics Inc Cash Flow Reinvestment Rate (2011–2025)
Historical reinvestment intensity for NeoGenomics Inc across 11 annual periods. Explore how much of NeoGenomics Inc's assets are long-term investments to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for NeoGenomics Inc (2011–2025)
Year-by-year capital reinvestment analysis for NeoGenomics Inc. For live market cap and broader valuation context, see NeoGenomics Inc market cap and net worth.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 8.90x | $46.57 Million | $5.23 Million | $27.01 Million | ▲ +16.0% |
| 2024 | 7.68x | $53.92 Million | $7.02 Million | $41.06 Million | ▼ -90.8% |
| 2020 | 83.86x | $122.44 Million | $1.46 Million | $29.10 Million | ▲ +4841.7% |
| 2019 | 1.70x | $39.66 Million | $23.37 Million | $20.03 Million | ▼ -50.6% |
| 2018 | 3.44x | $154.00 Million | $44.79 Million | $14.31 Million | ▲ +126.5% |
| 2017 | 1.52x | $27.38 Million | $18.04 Million | $13.69 Million | ▲ +132.3% |
| 2016 | 0.65x | $14.04 Million | $21.48 Million | $7.54 Million | ▲ +88.6% |
| 2015 | 0.35x | $2.21 Million | $6.39 Million | $2.21 Million | ▼ -13.2% |
| 2014 | 0.40x | $3.77 Million | $9.45 Million | $3.77 Million | ▼ -55.8% |
| 2013 | 0.90x | $2.01 Million | $2.23 Million | $2.01 Million | ▼ -93.1% |
| 2011 | 13.00x | $897.00K | $69.00K | $897.00K | — |